Central Neurocytoma
Journal Title: Journal of Neurological Sciences-Turkish - Year 2005, Vol 22, Issue 3
Abstract
Central neurocytomas are rare benign tumors of central nervous system, typically located in the supratentorial ventricles in young adults. Three main differential diagnosis are oligodendroglioma, nöroblastoma and ependymoma. Immunohistochemical studies are very important for the diagnosis of central neurocytoma. In this report a case of 67 year old male with central neurocytoma whom diagnosed incidentally is described. In this report we present a case of central neurocytoma who was operated via a transcallosal approach.
Authors and Affiliations
Cem DINC, Ahmet IPLIKCIOGLU, Deniz OZCAN, Kerem BIKMAZ, Azmi TUFAN, Serkan KOSDERE, Mustafa HATIBOGLU
Keywords
Related Articles
- EP ID EP139259
- DOI -
- Views 69
- Downloads 0
Sellar-parasellar epitelioid hemangioendoteliyoma
Epitelioid hemangioendotelioma çok ender görülen histolojik özellik ve biyolojik davranış olarak düşük derece malinite gösteren vasküler bir tümördür. Yazarlar kötü huylu bir sellar-parasellar olgu sunmaktadırlar. Öyküsü...
Onset of Epilepsy In Menopause: Presentation of 5 Cases
The distribution of epilepsy frequency is equal among women and men. However, menarche, pregnancy, menopause, hormone replacement therapy and use of oral contraceptives may affect the course of epilepsy in women. Few stu...
Lacunar Infarction Associated With Intracranial Venous Hypertension
Lacunar infarcts constitute a subtype of stroke with a diameter of less than 15 mm manifested by the presence of lacunar syndromes. The ischemic lesion in lacunar infarcts may often be caused by occlusion of a single, sm...
Late Onset Poststroke Seizures
The most common cause of seizures is cerebrovascular disease in elderly population. Late onset seizures are not investigated as well as early onset seizures in patients with stroke. There is no common consensus about cli...
Statins For The Treatment of Multiple Sclerosis
The limited effectiveness, adverse events as well as expensiveness of approved treatments for multiple sclerosis (MS) emphasize the need for the development of new therapies. Recent data suggest that statins, 3-hydroxy-3...